What is Syngene International Limited's latest revenue?

Syngene International Limited reported revenue of ₹3,739 Cr in its latest annual results, per the filed results.

What is Syngene International Limited's latest net profit?

Syngene International Limited reported net profit of ₹317 Cr in its latest annual results, per the filed results.

What is Syngene International Limited's return on equity?

Syngene International Limited posted ROE of 4.6% and ROCE of 6.2% for its latest annual results, computed from filed statements.

What is Syngene International Limited's operating margin?

Syngene International Limited's operating margin was 19.6% in its latest annual results, derived from filed operating expenses.

How much did Syngene International Limited's revenue grow year-on-year?

Syngene International Limited's revenue changed 4.4% year-on-year in its latest annual results, per the filed results.

SYN

SYNGENE

Name: Syngene International Limited (SYNGENE) quarterly results & financial statements
Creator: Upmazing

Syngene International Limited

HealthcareNIFTY Smallcap 250

ISIN INE398R01022

—

Day

52W

MCap₹15,969 Cr

weakUpmazing Score

Open chart ↗

SYN

SYNGENE

Syngene International Limited

HealthcareNIFTY Smallcap 250

ISIN INE398R01022

—

Day

52W

MCap₹15,969 Cr

weakUpmazing Score

Open chart ↗

Syngene International Limited (SYNGENE) reported revenue of ₹736 Cr and a net loss of ₹9.00 Cr for the quarter ended 2026-06-30. Figures are parsed from the company's filed results.

SYNGENE fundamentals, Fundamental score 42/100

The statements below are read from Syngene International Limited’s filed results, 28 filed quarters and 9 fiscal years on record, consolidated basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.

Latest: Q1 FY26-27 · filed Jul 30, 2026 · audited

Sales CAGR · 3Y+5.4%FY22 → FY25

Sales CAGR · 4Y+9.5%FY21 → FY25

PAT CAGR · 3Y−12.0%FY22 → FY25

PAT CAGR · 4Y−5.4%FY21 → FY25

Price · 1Y−39.8%EOD

Price CAGR · 3Y−21.2%EOD

Quarterly resultsConsolidated

₹ Cr	Jun2019	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026Latest	YoYlatest
Sales	421	519	607	422	520	585	659	595	610	641	758	645	768	786	994	808	910	854	917	790	891	944	1,018	875	911	917	1,037	736	-15.8%
	300	366	403	297	364	408	443	430	433	438	508	472	552	555	680	596	656	622	600	620	646	660	674	668	711	708	733	645	-3.4%
Operating profit	121	154	204	125	156	176	215	165	177	203	250	173	217	231	314	212	254	232	317	170	245	284	344	206	200	209	303	90.8	-56.0%
OPM %	28.8%	29.6%	33.6%	29.5%	30.0%	30.1%	32.7%	27.8%	29.1%	31.7%	33.0%	26.8%	28.2%	29.4%	31.6%	26.2%	27.9%	27.1%	34.6%	21.5%	27.5%	30.1%	33.8%	23.6%	21.9%	22.8%	29.3%	12.3%	-11.3 pp
Other income	20.5	20.0	20.5	15.3	13.8	17.1	18.4	12.3	12.9	12.9	14.7	15.5	15.4	17.2	22.8	23.6	21.6	29.3	16.1	18.1	16.5	18.3	18.9	17.7	15.4	15.4	22.2	25.3	+42.9%
Interest	7.10	9.80	9.30	7.40	6.60	7.10	6.60	7.90	1.20	9.40	5.60	9.40	11.7	13.7	10.4	10.5	13.0	10.8	12.9	11.7	13.1	12.4	15.9	11.6	13.2	11.9	12.1	9.60	-17.2%
Depreciation	47.4	57.0	62.3	66.1	68.7	69.7	70.0	74.7	76.2	78.5	80.3	86.1	90.2	94.6	95.6	102	105	108	111	107	111	109	106	111	117	114	112	112	+0.9%
Profit before tax	87.1	107	153	66.3	94.2	117	192	94.7	82.2	128	179	92.8	130	140	231	123	151	138	209	101	137	181	241	101	85.2	28.4	196	-19.2	-119.0%
Tax %	17.3%	14.0%	21.4%	12.5%	10.7%	12.3%	16.4%	18.4%	18.9%	19.0%	17.5%	20.4%	21.5%	21.6%	22.6%	24.0%	22.7%	19.3%	9.8%	25.3%	22.7%	27.5%	23.8%	14.4%	21.2%	47.2%	24.5%	n/a (loss)	—
Net profit	72.0	91.8	120	58.0	84.1	102	161	77.3	66.7	104	148	73.9	102	110	179	93.4	117	112	189	75.7	106	131	183	86.7	67.1	15.0	148	-9.00	-110.4%
EPS (₹)	1.82	2.32	3.03	1.47	2.12	2.57	4.04	1.91	1.64	2.57	3.71	1.85	2.55	2.74	4.46	2.33	2.90	2.78	4.70	1.89	2.64	3.27	4.56	2.16	1.67	0.37	3.68	-0.22	-110.2%

One column per filed quarter · ₹ crore · YoY = latest vs the same quarter a year back · EPS restated for bonus/split · n/a (loss) = tax rate undefined on a loss↔ scroll for earlier quarters

Revenue & net profit trend

last 20 quarters

RevenueNet profit

Revenue & net profit — Consolidated20 quarters

Segment results

Needs segment dataSegment results not parsedPer-segment revenue, EBIT margin and YoY arrive once we parse the segment annexure from the filing.

Forensic checksauto-scanned from the filing

Coming soonForensic checks not connectedAuditor opinion, OCF÷PAT, contingent liabilities, related-party share and working-capital days arrive as we parse the notes-to-accounts + cash-flow statement. Promoter-pledge is already on the Holdings tab.

How results moved the priceEOD reaction on the session the market could trade the filing

Avg absolute result-day move ±3.7%· EPS surprise: no estimates source

Q1'27filed Wed 29 Jul 17:36 · first tradeable session Thu 30 Julgap −5.6%close −3.6%

Q4'26filed Wed 29 Apr 19:48 · first tradeable session Thu 30 Aprgap −0.0%close +8.2%

Q3'26filed Thu 22 Jan 20:05 · first tradeable session Fri 23 Jangap −5.0%close −8.2%

Q2'26filed Wed 5 Nov 20:44 · first tradeable session Thu 6 Novgap −1.7%close −4.0%

Q1'26filed Wed 23 Jul 15:08 · traded that sessiongap −0.3%close +0.7%

Q4'25filed Wed 23 Apr 19:54 · first tradeable session Thu 24 Aprgap −7.8%close −12.8%

Q3'25filed Thu 23 Jan 15:06 · traded that sessiongap −0.4%close +2.3%

Q2'25filed Wed 23 Oct 15:25 · traded that sessiongap +0.0%close −0.2%

Q1'25filed Wed 24 Jul 15:04 · traded that sessiongap +0.2%close −1.6%

Q4'24filed Wed 24 Apr 19:51 · first tradeable session Thu 25 Aprgap −1.7%close +0.7%

Q3'24filed Thu 25 Jan 14:35 · traded that sessiongap +0.5%close −1.5%

Q2'24filed Tue 17 Oct 18:43 · first tradeable session Wed 18 Octgap −2.5%close −6.7%

Q1'24filed Wed 26 Jul 15:26 · traded that sessiongap +0.2%close −1.9%

Q4'23filed Wed 26 Apr 18:54 · first tradeable session Thu 27 Aprgap +3.2%close +4.1%

Q3'23filed Mon 23 Jan 20:02 · first tradeable session Tue 24 Jangap −0.4%close −4.0%

Q2'23filed Wed 19 Oct 14:24 · traded that sessiongap −0.9%close +6.3%

Q1'23filed Wed 20 Jul 13:55 · traded that sessiongap +0.9%close −1.5%

Q4'22filed Wed 27 Apr 14:39 · traded that sessiongap −2.0%close −1.6%

Q3'22filed Wed 19 Jan 20:57 · first tradeable session Thu 20 Jangap +1.0%close +2.4%

Q2'22filed Wed 20 Oct 21:25 · first tradeable session Thu 21 Octgap −2.0%close −1.7%

PeriodQ1 FY26-27BasisConsolidatedFiledJul 30, 2026Qualityaudited

Frequently Asked Questions

What is Syngene International Limited's latest revenue?: Syngene International Limited reported revenue of ₹3,739 Cr in its latest annual results, per the filed results.
What is Syngene International Limited's latest net profit?: Syngene International Limited reported net profit of ₹317 Cr in its latest annual results, per the filed results.
What is Syngene International Limited's return on equity?: Syngene International Limited posted ROE of 4.6% and ROCE of 6.2% for its latest annual results, computed from filed statements.
What is Syngene International Limited's operating margin?: Syngene International Limited's operating margin was 19.6% in its latest annual results, derived from filed operating expenses.
How much did Syngene International Limited's revenue grow year-on-year?: Syngene International Limited's revenue changed 4.4% year-on-year in its latest annual results, per the filed results.